BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Johns Hopkins Technology Ventures - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Johns Hopkins Technology Ventures
X-ORIGINAL-URL:https://ventures.jhu.edu
X-WR-CALDESC:Events for Johns Hopkins Technology Ventures
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220511T083000
DTEND;TZID=America/New_York:20220511T093000
DTSTAMP:20260607T172830
CREATED:20220406T191018Z
LAST-MODIFIED:20220412T194118Z
UID:26091-1652257800-1652261400@ventures.jhu.edu
SUMMARY:Reflections on Academic Translation and Therapeutic Development with Kathy High\, M.D.\, Founder of Spark Therapeutics
DESCRIPTION:You are invited to a virtual breakfast chat to listen as gene therapy pioneer Dr. Kathy High tells us her story: that of a clinician researcher whose accomplishments in basic\, translational\, and clinical investigation include the founding of Spark Therapeutics\, the $4.8B company behind Luxturna®\, the first gene therapy for genetic disease to obtain regulatory approval in the U.S. and Europe. In conversation with JHTV’s Christy Wyskiel\, Dr. High will reflect on academic-industry collaborations\, academic venture creation\, and the future of gene therapy. \nRegister today to join us on May 11 from 8:30-9:30 a.m. via Zoom. We look forward to seeing you there. \nSPEAKER BIOS\nKathy High\, M.D.\nAn Emeritus Professor at the Perelman School of Medicine at the University of Pennsylvania\, her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of studies that characterized the human immune response to adeno-associated viral (AAV) vectors in a variety of target tissues. Kathy’s work has evolved to encompass clinical translation of potential gene therapies for multiple inherited disorders. As the director of the Center for Cellular and Molecular Therapeutics at the Children’s Hospital of Philadelphia (CHOP)\, Kathy assembled a multidisciplinary team of scientists and researchers working to discover new gene and cell therapies for genetic diseases and to facilitate rapid translation of preclinical discoveries into clinical application. She was the co-founder\, president\, and chief scientific officer of Spark Therapeutics and currently serves as President of Therapeutics at AskBio. She served a five-year term on the FDA Advisory Committee on Cell\, Tissue\, and Gene Therapies and is a past president of the American Society of Gene & Cell Therapy (ASGCT). She received her A.B. in chemistry from Harvard University\, an M.D. from the University of North Carolina School of Medicine\, a business certification from the University of North Carolina Business School Management Institute for Hospital Administrators\, and an M.A. from the University of Pennsylvania. \nChristy Wyskiel\nAs the Senior Advisor to the President of Johns Hopkins University for Innovation and Entrepreneurship\, Christy also serves as the Executive Director of Johns Hopkins Technology Ventures\, the division of the university responsible for technology transfer\, industry research partnerships\, and company incubation under the brand ‘FastForward.’ Christy co-founded two Baltimore based startups and served as a formal and informal advisor to many others.  Prior to that\, Christy worked as an institutional investor where she had a long track record of successful investing in both public and private companies.
URL:https://ventures.jhu.edu/event/kathy-high-md-reflections-academic-translation-therapeutic-development/
LOCATION:Zoom
CATEGORIES:Pava Center
END:VEVENT
END:VCALENDAR